IGF1 and Growth delay: Prior to the discovery of the JAK1GOF variant, patient III-1 underwent clinical evaluation for growth failure, and the growth hormone (GH) signaling axis was assessed by measuring serum levels of insulin-like growth factor (IGF-1), which is produced by the liver in response to GH.